NCT03031041

Brief Summary

Carpal tunnel syndrome (CTS) is the most common peripheral entrapment neuropathy with involving compression of the median nerve in the carpal tunnel. Rather than other progressive disease, CTS is characterized by remission and recurrence. The hydrodissection could decrease the entrapment of nerve to restore blood supply. Despite the hydrodissection was pervasively used in clinical practice, current researches contain small participant without control group or randomized leading to foreseeable selection bias. The investigators design a randomized, double-blind, controlled trial to assess the effect of different method of ultrasound-guided hydrodissection in patients with CTS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 21, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 25, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

January 25, 2017

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2019

Completed
Last Updated

October 31, 2019

Status Verified

October 1, 2019

Enrollment Period

2.6 years

First QC Date

January 21, 2017

Last Update Submit

October 29, 2019

Conditions

Keywords

Hydrodissectionshort-axislong-axis

Outcome Measures

Primary Outcomes (1)

  • Change from baseline of severity of symptoms and functional status on 2nd week, 1st, 2nd, 3rd and 6th month after injection

    Boston carpal tunnel syndrome questionnaire (BCTQ) is a frequently used patient-based questionnaire for measurement of CTS which encompasses two components. In total, 11 questions and 8 items were evaluated to rate the symptom severity scale (SSS) and functional status scale (FSS), respectively. Both subscales range from 1 to 5 with a higher score indicating a higher degree of disability. The mean of total SSS and FSS divided with each item score were used for further analysis.

    Pre-treatment, 2nd week, 1st, 2nd, 3rd and 6th month after injection

Secondary Outcomes (4)

  • Change from baseline of pain on 2nd week, 1st, 2nd, 3rd and 6th month after injection

    Pre-treatment, 2nd week, 1st, 2nd, 3rd and 6th month after injection

  • Change from baseline of cross-sectional area of the median nerve on 2nd week, 1st, 2nd, 3rd and 6th month after injection

    Pre-treatment, 2nd week, 1st, 2nd, 3rd and 6th month after injection

  • Change from baseline of conduction velocity, amplitude of median nerve on 2nd week, 1st, 2nd, 3rd and 6th month after injection

    Pre-treatment, 2nd week, 1st, 2nd, 3rd and 6th month after injection

  • Change from baseline of finger pinch on 2nd week, 1st, 2nd, 3rd and 6th month after injection

    Pre-treatment, 2nd week, 1st, 2nd, 3rd and 6th month after injection

Study Arms (2)

Short-axis hydrodissection

EXPERIMENTAL

Ultrasound-guided short-axis hydrodissection with normal saline between carpal tunnel and median nerve

Procedure: Ultrasound-guided short-axis hydrodissection with 5cc normal saline

Long-axis hydrodissection

ACTIVE COMPARATOR

Ultrasound-guided long-axis hydrodissection with normal saline between carpal tunnel and median nerve

Procedure: Ultrasound-guided long-axis hydrodissection with 3cc normal saline

Interventions

Ultrasound-guided short-axis hydrodissection with 5cc normal saline between carpal tunnel and median nerve

Short-axis hydrodissection

Ultrasound-guided long-axis hydrodissection with 3cc normal saline between carpal tunnel and median nerve

Long-axis hydrodissection

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 20-80 year-old.
  • Diagnosis was confirmed using an electrophysiological study

You may not qualify if:

  • Cancer
  • Coagulopathy
  • Pregnancy
  • Inflammation status
  • Cervical radiculopathy
  • Polyneuropathy, brachial plexopathy
  • Thoracic outlet syndrome
  • Previously undergone wrist surgery or steroid injection for CTS

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital

Taipei, Neihu District, 886, Taiwan

Location

Related Publications (4)

  • DeLea SL, Chavez-Chiang NR, Poole JL, Norton HE, Sibbitt WL Jr, Bankhurst AD. Sonographically guided hydrodissection and corticosteroid injection for scleroderma hand. Clin Rheumatol. 2011 Jun;30(6):805-13. doi: 10.1007/s10067-010-1653-6. Epub 2011 Jan 15.

    PMID: 21234632BACKGROUND
  • Mulvaney SW. Ultrasound-guided percutaneous neuroplasty of the lateral femoral cutaneous nerve for the treatment of meralgia paresthetica: a case report and description of a new ultrasound-guided technique. Curr Sports Med Rep. 2011 Mar-Apr;10(2):99-104. doi: 10.1249/JSR.0b013e3182110096.

    PMID: 21623291BACKGROUND
  • Smith J, Wisniewski SJ, Finnoff JT, Payne JM. Sonographically guided carpal tunnel injections: the ulnar approach. J Ultrasound Med. 2008 Oct;27(10):1485-90. doi: 10.7863/jum.2008.27.10.1485.

  • Cass SP. Ultrasound-Guided Nerve Hydrodissection: What is it? A Review of the Literature. Curr Sports Med Rep. 2016 Jan-Feb;15(1):20-2. doi: 10.1249/JSR.0000000000000226.

MeSH Terms

Conditions

Carpal Tunnel Syndrome

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and Injuries

Study Officials

  • Yung-Tsan Wu, MD

    Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending Physician of Department of Physical Medicine and Rehabilitation

Study Record Dates

First Submitted

January 21, 2017

First Posted

January 25, 2017

Study Start

January 25, 2017

Primary Completion

August 30, 2019

Study Completion

August 30, 2019

Last Updated

October 31, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will share

Locations